Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaDocumentPhase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaAdăugat de Shiro0 evaluări0% au considerat acest document utilSalvați Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS Lymphoma pentru mai târziu